POPEYE Study - A 4 week randomised, double blind, placebo controlled, parallel group phase 2 proof of principle study to assess efficacy and safety of AZD1981 in adult patients with asthma

Trial Profile

POPEYE Study - A 4 week randomised, double blind, placebo controlled, parallel group phase 2 proof of principle study to assess efficacy and safety of AZD1981 in adult patients with asthma

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2012

At a glance

  • Drugs AZD 1981 (Primary)
  • Indications Asthma
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms POPEYE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 07 Nov 2012 Planned number of patients changed from 4 to 110.
    • 07 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top